Antioxidant responses and cellular adjustments to oxidative stress

Redox Biology

Volumn 6, Issue , 2015, Pages 183-197

  Espinosa Diez, Cristina ^a   Miguel, Verónica ^a   Mennerich, Daniela ^b   Kietzmann, Thomas ^b   Sánchez Pérez, Patricia ^c,d   Cadenas, Susana ^a,c,d   Lamas, Santiago ^a  

^a CENTRO DE BIOLOGÍA MOLECULAR SEVERO OCHOA   (Spain)

^b UNIVERSITY OF OULU   (Finland)

^c UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^d Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas   (Spain)

Author keywords

Antioxidants; ER stress; Ischemia reperfusion; Redox signaling; Transcription factors

Indexed keywords

GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KELCH LIKE ECH ASSOCIATED PROTEIN 1; MICRORNA; NUCLEOPHILE; OXIDIZING AGENT; PEROXIREDOXIN; THIOL; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR NRF2; ANTIOXIDANT; KEAP1 PROTEIN, HUMAN; NFE2L2 PROTEIN, HUMAN; SIGNAL PEPTIDE;

ANTIOXIDANT ACTIVITY; ENDOPLASMIC RETICULUM STRESS; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; ISCHEMIA; MOLECULAR INTERACTION; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHYSIOLOGICAL PROCESS; PRIORITY JOURNAL; PROTEIN PROCESSING; REPERFUSION; REVIEW; SIGNAL TRANSDUCTION; ADAPTATION; ANIMAL; CARDIOVASCULAR DISEASE; GENETICS; METABOLISM; PATHOLOGY; REPERFUSION INJURY;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; ANTIOXIDANTS; CARDIOVASCULAR DISEASES; ENDOPLASMIC RETICULUM STRESS; GENE EXPRESSION REGULATION; GLUTATHIONE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KELCH-LIKE ECH-ASSOCIATED PROTEIN 1; NF-E2-RELATED FACTOR 2; NF-KAPPA B; OXIDATIVE STRESS; PEROXIREDOXINS; REPERFUSION INJURY; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR AP-1;

EID: 84938300316     PISSN: 22132317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.redox.2015.07.008     Document Type: Review

References (253)

1. Hwang C., Sinskey A.J., Lodish H.F. Oxidized redox state of glutathione in the endoplasmic reticulum. Science 1992, 257(5076):1496-1502.
2. Pastore A., Piemonte F. S-glutathionylation signaling in cell biology: progress and prospects. Eur. J. Pharm. Sci. 2012, 46(5):279-292.
3. Ray P.D., Huang B.W., Tsuji Y. Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal. 2012, 24(5):981-990.
4. Rahman I., et al. Glutathione, stress responses, and redox signaling in lung inflammation. Antioxid. Redox Signal. 2005, 7(1-2):42-59.
5. Haddad J.J., Harb H.L. L-gamma-glutamyl-l-cysteinyl-glycine (glutathione; GSH) and GSH-related enzymes in the regulation of pro- and anti-inflammatory cytokines: a signaling transcriptional scenario for redox(y) immunologic sensor(s)?. Mol. Immunol. 2005, 42(9):987-1014.
6. Lu S.C. Glutathione synthesis. Biochim. Biophys. Acta 2013, 1830(5):3143-3153.
7. Lu S.C. Regulation of glutathione synthesis. Mol. Aspects Med. 2009, 30(1-2):42-59.
8. Forman H.J., Davies K.J., Ursini F. How do nutritional antioxidants really work: nucleophilic tone and para-hormesis versus free radical scavenging in vivo. Free Radic. Biol. Med. 2014, 66:24-35.
9. Oelze M., et al. Glutathione peroxidase-1 deficiency potentiates dysregulatory modifications of endothelial nitric oxide synthase and vascular dysfunction in aging. Hypertension 2014, 63(2):390-396.
10. Gallogly M.M., Mieyal J.J. Mechanisms of reversible protein glutathionylation in redox signaling and oxidative stress. Curr. Opin. Pharmacol. 2007, 7(4):381-391.
11. Martinez-Ruiz A., Lamas S. Signalling by NO-induced protein S-nitrosylation and S-glutathionylation: convergences and divergences. Cardiovasc. Res. 2007, 75(2):220-228.
12. Grek C.L., et al. Causes and consequences of cysteine S-glutathionylation. J. Biol. Chem. 2013, 288(37):26497-26504.
13. Chen C.A., et al. S-glutathionylation uncouples eNOS and regulates its cellular and vascular function. Nature 2010, 468(7327):1115-1118.
14. van Zwieten R., Verhoeven A.J., Roos D. Inborn defects in the antioxidant systems of human red blood cells. Free Radic. Biol. Med. 2014, 67:377-386.
15. Lubos E., Loscalzo J., Handy D.E. Glutathione peroxidase-1 in health and disease: from molecular mechanisms to therapeutic opportunities. Antioxid. Redox Signal. 2011, 15(7):1957-1997.
16. Imai H., Nakagawa Y. Biological significance of phospholipid hydroperoxide glutathione peroxidase (PHGPx, GPx4) in mammalian cells. Free Radic. Biol. Med. 2003, 34(2):145-169.
17. Rayman M.P. Selenium and human health. Lancet 2012, 379(9822):1256-1268.
18. Chen H., Tappel A.L. Protection of vitamin E, selenium, trolox C, ascorbic acid palmitate, acetylcysteine, coenzyme Q0, coenzyme Q10, beta-carotene, canthaxanthin, and (+)-catechin against oxidative damage to rat blood and tissues in vivo. Free Radic. Biol. Med. 1995, 18(5):949-953.
19. Fiala E.S., et al. Inhibition of 2-nitropropane-induced rat liver DNA and RNA damage by benzyl selenocyanate. Carcinogenesis 1997, 18(9):1809-1815.
20. Leibovitz B., Hu M.L., Tappel A.L. Dietary supplements of vitamin E, beta-carotene, coenzyme Q10 and selenium protect tissues against lipid peroxidation in rat tissue slices. J. Nutr. 1990, 120(1):97-104.
21. Fernandes A.P., Holmgren A. Glutaredoxins: glutathione-dependent redox enzymes with functions far beyond a simple thioredoxin backup system. Antioxid. Redox Signal. 2004, 6(1):63-74.
22. Wood Z.A., et al. Structure, mechanism and regulation of peroxiredoxins. Trends Biochem. Sci. 2003, 28(1):32-40.
23. Wood Z.A., Poole L.B., Karplus P.A. Peroxiredoxin evolution and the regulation of hydrogen peroxide signaling. Science 2003, 300(5619):650-653.
24. Hofmann B., Hecht H.J., Flohe L. Peroxiredoxins. Biol. Chem. 2002, 383(3-4):347-364.
25. Fujii J., Ikeda Y. Advances in our understanding of peroxiredoxin, a multifunctional, mammalian redox protein. Redox Rep. 2002, 7(3):123-130.
26. Oberley T.D., et al. Localization of the thioredoxin system in normal rat kidney. Free Radic. Biol. Med. 2001, 30(4):412-424.
27. Immenschuh S., et al. Differential cellular and subcellular localization of heme-binding protein 23/peroxiredoxin I and heme oxygenase-1 in rat liver. J. Histochem. Cytochem. 2003, 51(12):1621-1631.
28. Seo M.S., et al. Identification of a new type of mammalian peroxiredoxin that forms an intramolecular disulfide as a reaction intermediate. J. Biol. Chem. 2000, 275(27):20346-20354.
29. Winterbourn C.C., Metodiewa D. The reaction of superoxide with reduced glutathione. Arch. Biochem. Biophys. 1994, 314(2):284-290.
30. Winterbourn C.C. Reconciling the chemistry and biology of reactive oxygen species. Nat. Chem. Biol. 2008, 4(5):278-286.
31. Marinho H.S., et al. Hydrogen peroxide sensing, signaling and regulation of transcription factors. Redox Biol. 2014, 2:535-562.
32. Holmgren A., et al. Thiol redox control via thioredoxin and glutaredoxin systems. Biochem. Soc. Trans. 2005, 33(6):1375-1377.
33. Go Y.M., Jones D.P. Redox control systems in the nucleus: mechanisms and functions. Antioxid. Redox Signal. 2010, 13(4):489-509.
34. McCord J.M., Fridovich I. Superoxide dismutases: you've come a long way, baby. Antioxid. Redox Signal. 2014, 20(10):1548-1549.
35. Hileman E.A., Achanta G., Huang P. Superoxide dismutase: an emerging target for cancer therapeutics. Expert Opin. Ther. Targets 2001, 5(6):697-710.
36. Konzack A., Kietzmann T. Manganese superoxide dismutase in carcinogenesis: friend or foe?. Biochem. Soc. Trans. 2014, 42(4):1012-1016.
37. Gongora M.C., et al. Role of extracellular superoxide dismutase in hypertension. Hypertension 2006, 48(3):473-481.
38. Motohashi H., Yamamoto M. Nrf2-Keap1 defines a physiologically important stress response mechanism. Trends Mol. Med. 2004, 10(11):549-557.
39. Baird L., Dinkova-Kostova A.T. The cytoprotective role of the Keap1-Nrf2 pathway. Arch. Toxicol. 2011, 85(4):241-272.
40. Motohashi H., et al. Integration and diversity of the regulatory network composed of Maf and CNC families of transcription factors. Gene 2002, 294(1-2):1-12.
41. Zhang D.D., et al. Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex. Mol. Cell. Biol. 2004, 24(24):10941-10953.
42. McMahon M., et al. Dimerization of substrate adaptors can facilitate cullin-mediated ubiquitylation of proteins by a "tethering" mechanism: a two-site interaction model for the Nrf2-Keap1 complex. J. Biol. Chem. 2006, 281(34):24756-24768.
43. Tong K.I., et al. Two-site substrate recognition model for the Keap1-Nrf2 system: a hinge and latch mechanism. Biol. Chem. 2006, 387(10-11):1311-1320.
44. McMahon M., et al. Redox-regulated turnover of Nrf2 is determined by at least two separate protein domains, the redox-sensitive Neh2 degron and the redox-insensitive Neh6 degron. J. Biol. Chem. 2004, 279(30):31556-31567.
45. Nguyen T., et al. Increased protein stability as a mechanism that enhances Nrf2-mediated transcriptional activation of the antioxidant response element. Degradation of Nrf2 by the 26S proteasome. J. Biol. Chem. 2003, 278(7):4536-4541.
46. Sun Z., et al. Keap1 controls postinduction repression of the Nrf2-mediated antioxidant response by escorting nuclear export of Nrf2. Mol. Cell. Biol. 2007, 27(18):6334-6349.
47. Kobayashi A., et al. Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Mol. Cell. Biol. 2004, 24(16):7130-7139.
48. Cullinan S.B., et al. The Keap1-BTB protein is an adaptor that bridges Nrf2 to a Cul3-based E3 ligase: oxidative stress sensing by a Cul3-Keap1 ligase. Mol. Cell. Biol. 2004, 24(19):8477-8486.
49. Furukawa M., Xiong Y. BTB protein Keap1 targets antioxidant transcription factor Nrf2 for ubiquitination by the Cullin 3-Roc1 ligase. Mol. Cell. Biol. 2005, 25(1):162-171.
50. Kobayashi A., et al. Oxidative and electrophilic stresses activate Nrf2 through inhibition of ubiquitination activity of Keap1. Mol. Cell. Biol. 2006, 26(1):221-229.
51. Dinkova-Kostova A.T., et al. Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proc. Natl. Acad. Sci. USA 2002, 99(18):11908-11913.
52. Fourquet S., et al. Activation of NRF2 by nitrosative agents and H2O2 involves KEAP1 disulfide formation. J. Biol. Chem. 2010, 285(11):8463-8471.
53. Yamamoto T., et al. Physiological significance of reactive cysteine residues of Keap1 in determining Nrf2 activity. Mol. Cell. Biol. 2008, 28(8):2758-2770.
54. Rushmore T.H., Morton M.R., Pickett C.B. The antioxidant responsive element. Activation by oxidative stress and identification of the DNA consensus sequence required for functional activity. J. Biol. Chem. 1991, 266(18):11632-11639.
55. Ma Q., He X. Molecular basis of electrophilic and oxidative defense: promises and perils of Nrf2. Pharmacol. Rev. 2012, 64(4):1055-1081.
56. Chen W., et al. Direct interaction between Nrf2 and p21(Cip1/WAF1) upregulates the Nrf2-mediated antioxidant response. Mol. Cell 2009, 34(6):663-673.
57. Komatsu M., et al. The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1. Nat. Cell Biol. 2010, 12(3):213-223.
58. Chowdhry S., et al. Nrf2 is controlled by two distinct beta-TrCP recognition motifs in its Neh6 domain, one of which can be modulated by GSK-3 activity. Oncogene 2013, 32(32):3765-3781.
59. Malhotra D., et al. Global mapping of binding sites for Nrf2 identifies novel targets in cell survival response through ChIP-Seq profiling and network analysis. Nucleic Acids Res. 2010, 38(17):5718-5734.
60. Ma Q., et al. Induction of murine NAD(P)H:quinone oxidoreductase by 2,3,7,8-tetrachlorodibenzo-p-dioxin requires the CNC (cap 'n' collar) basic leucine zipper transcription factor Nrf2 (nuclear factor erythroid 2-related factor 2): cross-interaction between AhR (aryl hydrocarbon receptor) and Nrf2 signal transduction. Biochem. J. 2004, 377(1):205-213.
61. Iida K., et al. Nrf2 and p53 cooperatively protect against BBN-induced urinary bladder carcinogenesis. Carcinogenesis 2007, 28(11):2398-2403.
62. Li W., et al. Activation of Nrf2-antioxidant signaling attenuates NFkappaB-inflammatory response and elicits apoptosis. Biochem. Pharmacol. 2008, 76(11):1485-1489.
63. Jain A.K., Mahajan S., Jaiswal A.K. Phosphorylation and dephosphorylation of tyrosine 141 regulate stability and degradation of INrf2: a novel mechanism in Nrf2 activation. J. Biol. Chem. 2008, 283(25):17712-17720.
64. Wakabayashi N., et al. Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation. Nat. Genet. 2003, 35(3):238-245.
65. Jiang T., et al. High levels of Nrf2 determine chemoresistance in type II endometrial cancer. Cancer Res. 2010, 70(13):5486-5496.
66. Ghosh S., May M.J., Kopp E.B. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 1998, 225-260.
67. Oliveira-Marques V., et al. Role of hydrogen peroxide in NF-kappaB activation: from inducer to modulator. Antioxid. Redox Signal. 2009, 11(9):2223-2243.
68. Jung Y., et al. Dynein light chain LC8 negatively regulates NF-kappaB through the redox-dependent interaction with IkappaBalpha. J. Biol. Chem. 2008, 283(35):23863-23871.
69. Lee D.F., et al. KEAP1 E3 ligase-mediated downregulation of NF-kappaB signaling by targeting IKKbeta. Mol. Cell 2009, 36(1):131-140.
70. Pham C.G., et al. Ferritin heavy chain upregulation by NF-kappaB inhibits TNFalpha-induced apoptosis by suppressing reactive oxygen species. Cell 2004, 119(4):529-542.
71. Kamata H., et al. Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 2005, 120(5):649-661.
72. Rius J., et al. NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature 2008, 453(7196):807-811.
73. Ma Q., et al. Inhibition of nuclear factor kappaB by phenolic antioxidants: interplay between antioxidant signaling and inflammatory cytokine expression. Mol. Pharmacol. 2003, 64(2):211-219.
74. Karin M., et al. Oxidative stress and gene expression: the AP-1 and NF-kappaB connections. Biofactors 2001, 15(2-4):87-89.
75. Whitmarsh A.J., Davis R.J. Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. J. Mol. Med. (Berl) 1996, 74(10):589-607.
76. Pinkus R., Weiner L.M., Daniel V. Role of oxidants and antioxidants in the induction of AP-1, NF-kappaB, and glutathione S-transferase gene expression. J. Biol. Chem. 1996, 271(23):13422-13429.
77. Kowaltowski A.J., Castilho R.F., Vercesi A.E. Mitochondrial permeability transition and oxidative stress. FEBS Lett. 2001, 495(1-2):12-15.
78. Ronchi J.A., Vercesi A.E., Castilho R.F. Reactive oxygen species and permeability transition pore in rat liver and kidney mitoplasts. J. Bioenergy Biomembr. 2011, 43(6):709-715.
79. Halestrap A.P., Pasdois P. The role of the mitochondrial permeability transition pore in heart disease. Biochim. Biophys. Acta 2009, 1787(11):1402-1415.
80. Lee R.C., Feinbaum R.L., Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993, 75(5):843-854.
81. Wightman B., Ha I., Ruvkun G. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 1993, 75(5):855-862.
82. Kozomara A., Griffiths-Jones S. miRBase: annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res. 2014, 42(Database issue):D68-D73.
83. Kim W., et al. Histone acetyltransferase GCN5 interferes with the miRNA pathway in Arabidopsis. Cell Res. 2009, 19(7):899-909.
84. Ying S.Y., Lin S.L. Intron-derived microRNAs-fine tuning of gene functions. Gene 2004, 342(1):25-28.
85. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116(2):281-297.
86. Lagos-Quintana M., et al. Identification of novel genes coding for small expressed RNAs. Science 2001, 294(5543):853-858.
87. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136(2):215-233.
88. Cheng X., Ku C.H., Siow R.C. Regulation of the Nrf2 antioxidant pathway by microRNAs: new players in micromanaging redox homeostasis. Free Radic. Biol. Med. 2013, 64:4-11.
89. Stachurska A., et al. Cross-talk between microRNAs, nuclear factor E2-related factor 2, and heme oxygenase-1 in ochratoxin A-induced toxic effects in renal proximal tubular epithelial cells. Mol. Nutr. Food Res. 2013, 57(3):504-515.
90. Narasimhan M., et al. Identification of novel microRNAs in post-transcriptional control of Nrf2 expression and redox homeostasis in neuronalSH-SY5Y cells. PLoS One 2012, 7(12):e51111.
91. Papp D., et al. The NRF2-related interactome and regulome contain multifunctional proteins and fine-tuned autoregulatory loops. FEBS Lett. 2012, 586(13):1795-1802.
92. Eades G., et al. miR-200 a regulates Nrf2 activation by targeting Keap1 mRNA in breast cancer cells. J. Biol. Chem. 2011, 286(47):40725-40733.
93. Hou W., et al. MicroRNA-196 represses Bach1 protein and hepatitis C virus gene expression in human hepatoma cells expressing hepatitis C viral proteins. Hepatology 2010, 51(5):1494-1504.
94. Sangokoya C., Telen M.J., Chi J.T. microRNA miR-144 modulates oxidative stress tolerance and associates with anemia severity in sickle cell disease. Blood 2010, 116(20):4338-4348.
95. Yang M., et al. MiR-28 regulates Nrf2 expression through a Keap1-independent mechanism. Breast Cancer Res. Treat. 2011, 129(3):983-991.
96. Yang H., et al. Activation of a novel c-Myc-miR27-prohibitin 1 circuitry in cholestatic liver injury inhibits glutathione synthesis in mice. Antioxid. Redox Signal. 2015, 22(3):259-274.
97. Do M.T., et al. Metformin induces microRNA-34 a to downregulate the Sirt1/Pgc-1alpha/Nrf2 pathway, leading to increased susceptibility of wild-type p53 cancer cells to oxidative stress and therapeutic agents. Free Radic. Biol. Med. 2014, 74:21-34.
98. Huang X., et al. The role of miR-34 a in the hepatoprotective effect of hydrogen sulfide on ischemia/reperfusion injury in young and old rats. PLoS One 2014, 9(11):e113305.
99. Li N., et al. Increased expression of miR-34 a and miR-93 in rat liver during aging, and their impact on the expression of Mgst1 and Sirt1. Mech. Ageing Dev. 2011, 132(3):75-85.
100. Yang J.J., et al. MicroRNA-200 a controls Nrf2 activation by target Keap1 in hepatic stellate cell proliferation and fibrosis. Cell Signal. 2014, 26(11):2381-2389.
101. Pulkkinen K.H., Yla-Herttuala S., Levonen A.L. Heme oxygenase 1 is induced by miR-155 via reduced BACH1 translation in endothelial cells. Free Radic. Biol. Med. 2011, 51(11):2124-2131.
102. Boesch-Saadatmandi C., et al. Effect of quercetin and its metabolites isorhamnetin and quercetin-3-glucuronide on inflammatory gene expression: role of miR-155. J. Nutr. Biochem. 2011, 22(3):293-299.
103. Li S., et al. microRNA-155 silencing inhibits proliferation and migration and induces apoptosis by upregulating BACH1 in renal cancer cells. Mol. Med. Rep. 2012, 5(4):949-954.
104. Espinosa-Diez C., et al. Targeting of gamma-glutamyl-cysteine ligase by miR-433 reduces glutathione biosynthesis and promotes TGF-beta-dependent fibrogenesis. Antioxid. Redox Signal. 2014.
105. Ungvari Z., et al. Aging-induced dysregulation of dicer1-dependent microRNA expression impairs angiogenic capacity of rat cerebromicrovascular endothelial cells. J. Gerontol. A Biol. Sci. Med. Sci. 2013, 68(8):877-891.
106. Wiesen J.L., Tomasi T.B. Dicer is regulated by cellular stresses and interferons. Mol. Immunol. 2009, 46(6):1222-1228.
107. O'Connell R.M., et al. Physiological and pathological roles for microRNAs in the immune system. Nat. Rev. Immunol. 2010, 10(2):111-122.
108. Leung A.K., Sharp P.A. MicroRNA functions in stress responses. Mol. Cell 2010, 40(2):205-215.
109. Sato F., et al. MicroRNAs and epigenetics. FEBS J. 2011, 278(10):1598-1609.
110. Cyr A.R., Domann F.E. The redox basis of epigenetic modifications: from mechanisms to functional consequences. Antioxid. Redox Signal. 2011, 15(2):551-589.
111. Fu Y., et al. Regulation of NADPH oxidase activity is associated with miRNA-25-mediated NOX4 expression in experimental diabetic nephropathy. Am. J. Nephrol. 2010, 32(6):581-589.
112. Chan S.Y., et al. MicroRNA-210 controls mitochondrial metabolism during hypoxia by repressing the iron-sulfur cluster assembly proteins ISCU1/2. Cell Metab. 2009, 10(4):273-284.
113. Tak H., et al. miR-27 regulates mitochondrial networks by directly targeting the mitochondrial fission factor. Exp. Mol. Med. 2014, 46:e123.
114. Bai X.Y., et al. miR-335 and miR-34 a Promote renal senescence by suppressing mitochondrial antioxidative enzymes. J. Am. Soc. Nephrol. 2011, 22(7):1252-1261.
115. Li R., et al. MicroRNA-145 protects cardiomyocytes against hydrogen peroxide (H(2)O(2))-induced apoptosis through targeting the mitochondria apoptotic pathway. PLoS One 2012, 7(9):e44907.
116. Wang H., et al. MicroRNA-181 c targets Bcl-2 and regulates mitochondrial morphology in myocardial cells. J. Cell Mol. Med. 2015.
117. Dang K., Myers K.A. The role of hypoxia-induced miR-210 in cancer progression. Int. J. Mol. Sci. 2015, 16(3):6353-6372.
118. Yamamoto H., et al. MicroRNA-494 regulates mitochondrial biogenesis in skeletal muscle through mitochondrial transcription factor A and Forkhead box j3. Am. J. Physiol. Endocrinol. Metab. 2012, 303(12):E1419-E1427.
119. Bartoszewska S., et al. Regulation of the unfolded protein response by microRNAs. Cell. Mol. Biol. Lett. 2013, 18(4):555-578.
120. Byrd A.E., Brewer J.W. Micro(RNA)managing endoplasmic reticulum stress. IUBMB Life 2013, 65(5):373-381.
121. Greco S., Gaetano C., Martelli F. HypoxamiR regulation and function in ischemic cardiovascular diseases. Antioxid. Redox Signal. 2014, 21(8):1202-1219.
122. Yao M., et al. Dicer mediating the expression of miR-143 and miR-155 regulates hexokinase II associated cellular response to hypoxia. Am. J. Physiol.-Lung Cell. Mol. Physiol. 2014, 307(11):L829-L837.
123. Qin Q., Furong W., Baosheng L. Multiple functions of hypoxia-regulated miR-210 in cancer. J. Exp. Clin. Cancer Res. 2014, 33:50.
124. Rink C., Khanna S. MicroRNA in ischemic stroke etiology and pathology. Physiol. Genomics 2011, 43(10):521-528.
125. Kauppinen A., et al. Antagonistic crosstalk between NF-kappaB and SIRT1 in the regulation of inflammation and metabolic disorders. Cell Signal. 2013, 25(10):1939-1948.
126. Song M.A., et al. Differential expression of microRNAs in ischemic heart disease. Drug Discov. Today 2015, 20(2):223-235.
127. Kim H.J., et al. Carbon monoxide protects against hepatic ischemia/reperfusion injury by modulating the miR-34 a/SIRT1 pathway. Biochim. Biophys. Acta 2015, 1852(7):1550-1559.
128. Forman H.J., Traber M., Ursini F. Antioxidants: GRABbing new headlines. Free Radic. Biol. Med. 2014, 66:1-2.
129. Sies H. Oxidative stress: a concept in redox biology and medicine. Redox Biol. 2015, 4:180-183.
130. Jones D.P., Sies H. The redox code. Antioxid. Redox Signal. 2015.
131. van der Vlies D., et al. Oxidation of ER resident proteins upon oxidative stress: effects of altering cellular redox/antioxidant status and implications for protein maturation. Antioxid. Redox Signal. 2003, 5(4):381-387.
132. Fewell S.W., et al. The action of molecular chaperones in the early secretory pathway. Annu. Rev. Genet. 2001, 35:149-191.
133. Gorlach A., Klappa P., Kietzmann T. The endoplasmic reticulum: folding, calcium homeostasis, signaling, and redox control. Antioxid. Redox Signal. 2006, 8(9-10):1391-1418.
134. Ramming T., Appenzeller-Herzog C. The physiological functions of mammalian endoplasmic oxidoreductin 1: on disulfides and more. Antioxid. Redox Signal. 2012, 16(10):1109-1118.
135. Hatahet F., Ruddock L.W. Protein disulfide isomerase: a critical evaluation of its function in disulfide bond formation. Antioxid. Redox Signal. 2009, 11(11):2807-2850.
136. Dorner A.J., Wasley L.C., Kaufman R.J. Increased synthesis of secreted proteins induces expression of glucose-regulated proteins in butyrate-treated Chinese hamster ovary cells. J. Biol. Chem. 1989, 264(34):20602-20607.
137. Kozutsumi Y., et al. The presence of malfolded proteins in the endoplasmic reticulum signals the induction of glucose-regulated proteins. Nature 1988, 332(6163):462-464.
138. Harding H.P., Zhang Y., Ron D. Protein translation and folding are coupled by an endoplasmic-reticulum-resident kinase. Nature 1999, 397(6716):271-274.
139. Travers K.J., et al. Functional and genomic analyses reveal an essential coordination between the unfolded protein response and ER-associated degradation. Cell 2000, 101(3):249-258.
140. Kim P.S., Arvan P. Endocrinopathies in the family of endoplasmic reticulum (ER) storage diseases: disorders of protein trafficking and the role of ER molecular chaperones. Endocrine Rev. 1998, 19(2):173-202.
141. Aridor M., Hannan L.A. Traffic jams II: an update of diseases of intracellular transport. Traffic (Copenhagen, Denmark) 2002, 3(11):781-790.
142. Cullinan S.B., Diehl J.A. PERK-dependent activation of Nrf2 contributes to redox homeostasis and cell survival following endoplasmic reticulum stress. J. Biol. Chem. 2004, 279(19):20108-20117.
143. Tu B.P., Weissman J.S. Oxidative protein folding in eukaryotes: mechanisms and consequences. J. Cell Biol. 2004, 164(3):341-346.
144. Harding H.P., et al. An integrated stress response regulates amino acid metabolism and resistance to oxidative stress. Mol. Cell 2003, 11(3):619-633.
145. Cabibbo A., et al. ERO1-L, a human protein that favors disulfide bond formation in the endoplasmic reticulum. J. Biol. Chem. 2000, 275(7):4827-4833.
146. Pagani M., et al. Endoplasmic reticulum oxidoreductin 1-lbeta (ERO1-Lbeta), a human gene induced in the course of the unfolded protein response. J. Biol. Chem. 2000, 275(31):23685-23692.
147. Pagani M., et al. The C-terminal domain of yeast Ero1p mediates membrane localization and is essential for function. FEBS Lett. 2001, 508(1):117-120.
148. Mezghrani A., et al. Manipulation of oxidative protein folding and PDI redox state in mammalian cells. EMBO J. 2001, 20(22):6288-6296.
149. Molteni S.N., et al. Glutathione limits Ero1-dependent oxidation in the endoplasmic reticulum. J. Biol. Chem. 2004, 279(31):32667-32673.
150. Gilady S.Y., et al. Ero1alpha requires oxidizing and normoxic conditions to localize to the mitochondria-associated membrane (MAM). Cell Stress Chaperones 2010, 15(5):619-629.
151. Tu B.P., Weissman J.S. The FAD- and O(2)-dependent reaction cycle of Ero1-mediated oxidative protein folding in the endoplasmic reticulum. Mol. Cell 2002, 10(5):983-994.
152. Gross E., et al. Structure of Ero1p, source of disulfide bonds for oxidative protein folding in the cell. Cell 2004, 117(5):601-610.
153. Tavender T.J., Springate J.J., Bulleid N.J. Recycling of peroxiredoxin IV provides a novel pathway for disulphide formation in the endoplasmic reticulum. EMBO J. 2010, 29(24):4185-4197.
154. Zito E., et al. Oxidative protein folding by an endoplasmic reticulum-localized peroxiredoxin. Mol. Cell 2010, 40(5):787-797.
155. Ozawa K., et al. Expression of the oxygen-regulated protein ORP150 accelerates wound healing by modulating intracellular VEGF transport. J. Clin. Investig. 2001, 108(1):41-50.
156. Tobisawa S., et al. Mutant SOD1 linked to familial amyotrophic lateral sclerosis, but not wild-type SOD1, induces ER stress in COS7 cells and transgenic mice. Biochem. Biophys. Res. Commun. 2003, 303(2):496-503.
157. Tu P.H., et al. Oxidative stress, mutant SOD1, and neurofilament pathology in transgenic mouse models of human motor neuron disease. Lab. Investig. J. Tech. Methods Pathol. 1997, 76(4):441-456.
158. Bruening W., et al. Up-regulation of protein chaperones preserves viability of cells expressing toxic Cu/Zn-superoxide dismutase mutants associated with amyotrophic lateral sclerosis. J. Neurochem. 1999, 72(2):693-699.
159. Wong P.C., et al. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 1995, 14(6):1105-1116.
160. Shiu R.P., Pouyssegur J., Pastan I. Glucose depletion accounts for the induction of two transformation-sensitive membrane proteinsin Rous sarcoma virus-transformed chick embryo fibroblasts. Proc. Natl. Acad. Sci. USA 1977, 74(9):3840-3844.
161. Heacock C.S., Sutherland R.M. Enhanced synthesis of stress proteins caused by hypoxia and relation to altered cell growth and metabolism. Br. J. Cancer 1990, 62(2):217-225.
162. Ozawa K., et al. 150-kDa oxygen-regulated protein (ORP150) suppresses hypoxia-induced apoptotic cell death. J. Biol. Chem. 1999, 274(10):6397-6404.
163. Blais J.D., et al. Activating transcription factor 4 is translationally regulated by hypoxic stress. Mol. Cell. Biol. 2004, 24(17):7469-7482.
164. Estes S.D., Stoler D.L., Anderson G.R. Normal fibroblasts induce the C/EBP beta and ATF-4 bZIP transcription factors in response to anoxia. Exp. Cell Res. 1995, 220(1):47-54.
165. Liu Q., et al. A Fenton reaction at the endoplasmic reticulum is involved in the redox control of hypoxia-inducible gene expression. Proc. Natl. Acad. Sci. USA 2004, 101(12):4302-4307.
166. Koivunen P., et al. An endoplasmic reticulum transmembrane prolyl 4-hydroxylase is induced by hypoxia and acts on hypoxia-inducible factor alpha. J. Biol. Chem. 2007, 282(42):30544-30552.
167. Gess B., et al. The cellular oxygen tension regulates expression of the endoplasmic oxidoreductase ERO1-Lalpha. Eur. J. Biochem./FEBS 2003, 270(10):2228-2235.
168. Xue X., et al. Tumor necrosis factor alpha (TNFalpha) induces the unfolded protein response (UPR) in a reactive oxygen species (ROS)-dependent fashion, and the UPR counteracts ROS accumulation by TNFalpha. J. Biol. Chem. 2005, 280(40):33917-33925.
169. Yoneda T., et al. Activation of caspase-12, an endoplastic reticulum (ER) resident caspase, through tumor necrosis factor receptor-associated factor 2-dependent mechanism in response to the ER stress. J. Biol. Chem. 2001, 276(17):13935-13940.
170. Nakagawa T., et al. Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature 2000, 403(6765):98-103.
171. Rao R.V., et al. Coupling endoplasmic reticulum stress to the cell death program. Mechanism of caspase activation. J. Biol. Chem. 2001, 276(36):33869-33874.
172. Matsuzawa A., et al. Physiological roles of ASK1-mediated signal transduction in oxidative stress- and endoplasmic reticulum stress-induced apoptosis: advanced findings from ASK1 knockout mice. Antioxid. Redox Signal. 2002, 4(3):415-425.
173. Nishitoh H., et al. ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats. Genes Dev. 2002, 16(11):1345-1355.
174. Urano F., et al. Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1. Science 2000, 287(5453):664-666.
175. Tobiume K., et al. ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis. EMBO Rep. 2001, 2(3):222-228.
176. Oono K., et al. JAB1 participates in unfolded protein responses by association and dissociation with IRE1. Neurochem. Int. 2004, 45(5):765-772.
177. Burwell L.S., et al. Direct evidence for S-nitrosation of mitochondrial complex I. Biochem. J. 2006, 394(3):627-634.
178. Dahm C.C., Moore K., Murphy M.P. Persistent S-nitrosation of complex I and other mitochondrial membrane proteins by S-nitrosothiols but not nitric oxide or peroxynitrite: implications for the interaction of nitric oxide with mitochondria. J. Biol. Chem. 2006, 281(15):10056-10065.
179. Galkin A., Moncada S. S-nitrosation of mitochondrial complex I depends on its structural conformation. J. Biol. Chem. 2007, 282(52):37448-37453.
180. Shiva S., et al. Nitrite augments tolerance to ischemia/reperfusion injury via the modulation of mitochondrial electron transfer. J. Exp. Med. 2007, 204(9):2089-2102.
181. Nadtochiy S.M., Burwell L.S., Brookes P.S. Cardioprotection and mitochondrial S-nitrosation: effects of S-nitroso-2-mercaptopropionyl glycine (SNO-MPG) in cardiac ischemia-reperfusion injury. J. Mol. Cell. Cardiol. 2007, 42(4):812-825.
182. Murphy M.P. Mitochondrial thiols in antioxidant protection and redox signaling: distinct roles for glutathionylation and other thiol modifications. Antioxid. Redox Signal. 2012, 16(6):476-495.
183. Prime T.A., et al. A mitochondria-targeted S-nitrosothiol modulates respiration, nitrosates thiols, and protects against ischemia-reperfusion injury. Proc. Natl. Acad. Sci. USA 2009, 106(26):10764-10769.
184. Chouchani E.T., et al. Cardioprotection by S-nitrosation of a cysteine switch on mitochondrial complex I. Nat. Med. 2013, 19(6):753-759.
185. Borutaite V., Brown G.C. S-nitrosothiol inhibition of mitochondrial complex I causes a reversible increase in mitochondrial hydrogen peroxide production. Biochim. Biophys. Acta 2006, 1757(5-6):562-566.
186. Skyschally A., et al. Across-species transfer of protection by remote ischemic preconditioning with species-specific myocardial signal transduction by RISK and SAFE pathways. Circ. Res. 2015.
187. Imai S., et al. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 2000, 403(6771):795-800.
188. Shinmura K. Post-translational modification of mitochondrial proteins by caloric restriction: possible involvement in caloric restriction-induced cardioprotection. Trends Cardiovasc. Med. 2013, 23(1):18-25.
189. Anedda A., et al. The transcription factor Nrf2 promotes survival by enhancing the expression of uncoupling protein 3 under conditions of oxidative stress. Free Radic. Biol. Med. 2013, 61:395-407.
190. Leonard M.O., et al. Reoxygenation-specific activation of the antioxidant transcription factor Nrf2 mediates cytoprotective gene expression in ischemia-reperfusion injury. FASEB J. 2006, 20(14):2624-2626.
191. Wu J.X., et al. Curcumin pretreatment and post-treatment both improve the antioxidative ability of neurons with oxygen-glucose deprivation. Neural Regen. Res. 2015, 10(3):481-489.
192. Wang N.P., et al. Curcumin promotes cardiac repair and ameliorates cardiac dysfunction following myocardial infarction. Br. J. Pharmacol. 2012, 167(7):1550-1562.
193. Trujillo J., et al. Renoprotective effect of the antioxidant curcumin: recent findings. Redox Biol. 2013, 1:448-456.
194. Li W., et al. Novel curcumin analogue 14 p protects against myocardial ischemia reperfusion injury through Nrf2-activating anti-oxidative activity. Toxicol. Appl. Pharmacol. 2015, 282(2):175-183.
195. Zhao H.D., et al. Sulforaphane protects liver injury induced by intestinal ischemia reperfusion through Nrf2-ARE pathway. World J. Gastroenterol. 2010, 16(24):3002-3010.
196. Soane L., et al. Sulforaphane protects immature hippocampal neurons against death caused by exposure to hemin or to oxygen and glucose deprivation. J. Neurosci. Res. 2010, 88(6):1355-1363.
197. Danilov C.A., et al. Sulforaphane protects astrocytes against oxidative stress and delayed death caused by oxygen and glucose deprivation. Glia 2009, 57(6):645-656.
198. Piao C.S., et al. Sulforaphane protects ischemic injury of hearts through antioxidant pathway and mitochondrial K(ATP) channels. Pharmacol. Res. 2010, 61(4):342-348.
199. Yoon H.Y., et al. Sulforaphane protects kidneys against ischemia-reperfusion injury through induction of the Nrf2-dependent phase 2 enzyme. Biochem. Pharmacol. 2008, 75(11):2214-2223.
200. Li Z., et al. Sulforaphane protects hearts from early injury after experimental transplantation. Ann. Transplant. 2013, 18:558-566.
201. Anderson E.J., Katunga L.A., Willis M.S. Mitochondria as a source and target of lipid peroxidation products in healthy and diseased heart. Clin. Exp. Pharmacol. Physiol. 2012, 39(2):179-193.
202. Ma H., et al. Aldehyde dehydrogenase 2 (ALDH2) rescues myocardial ischaemia/reperfusion injury: role of autophagy paradox and toxic aldehyde. Eur. Heart J. 2011, 32(8):1025-1038.
203. Zhang Y., et al. 4-hydroxy-2-nonenal protects against cardiac ischemia-reperfusion injury via the Nrf2-dependent pathway. J. Mol. Cell. Cardiol. 2010, 49(4):576-586.
204. Lopez-Bernardo E., et al. 4-Hydroxynonenal induces Nrf2-mediated UCP3 upregulation in mouse cardiomyocytes. Free Radic. Biol. Med. 2015.
205. Cordeiro J.V., Jacinto A. The role of transcription-independent damage signals in the initiation of epithelial wound healing. Nat. Rev. Mol. Cell Biol. 2013, 14(4):249-262.
206. den Hertog J., Groen A., van der Wijk T. Redox regulation of protein-tyrosine phosphatases. Arch. Biochem. Biophys. 2005, 434(1):11-15.
207. Salmeen A., et al. Redox regulation of protein tyrosine phosphatase 1B involves a sulphenyl-amide intermediate. Nature 2003, 423(6941):769-773.
208. van Montfort R.L., et al. Oxidation state of the active-site cysteine in protein tyrosine phosphatase 1B. Nature 2003, 423(6941):773-777.
209. Claiborne A., et al. Protein-sulfenic acids: diverse roles for an unlikely player in enzyme catalysis and redox regulation. Biochemistry 1999, 38(47):15407-15416.
210. Gopalakrishna R., Jaken S. Protein kinase C signaling and oxidative stress. Free Radic. Biol. Med. 2000, 28(9):1349-1361.
211. Marshall C.J. MAP kinase kinase kinase, MAP kinase kinase and MAP kinase. Curr. Opin. Genet. Dev. 1994, 4(1):82-89.
212. Catarzi S., et al. Redox regulation of ERK1/2 activation induced by sphingosine 1-phosphate in fibroblasts: involvement of NADPH oxidase and platelet-derived growth factor receptor. Biochim. Biophys. Acta 2011, 1810(4):446-456.
213. Meng D., et al. Insulin-like growth factor-I (IGF-I) induces epidermal growth factor receptor transactivation and cell proliferation through reactive oxygen species. Free Radic. Biol. Med. 2007, 42(11):1651-1660.
214. Nagai H., et al. Pathophysiological roles of ASK1-MAP kinase signaling pathways. J. Biochem. Mol. Biol. 2007, 40(1):1-6.
215. Zhou J.Y., Liu Y., Wu G.S. The role of mitogen-activated protein kinase phosphatase-1 in oxidative damage-induced cell death. Cancer Res. 2006, 66(9):4888-4894.
216. Yu R., et al. Activation of mitogen-activated protein kinase pathways induces antioxidant response element-mediated gene expression via a Nrf2-dependent mechanism. J. Biol. Chem. 2000, 275(51):39907-39913.
217. Kim S.U., et al. Peroxiredoxin I is a ROS/p38 MAPK-dependent inducible antioxidant that regulates NF-kappaB-mediated iNOS induction and microglial activation. J. Neuroimmunol. 2013, 259(1-2):26-36.
218. Dhar A., Young M.R., Colburn N.H. The role of AP-1, NF-kappaB and ROS/NOS in skin carcinogenesis: the JB6 model is predictive. Mol. Cell. Biochem. 2002, 234-235(1-2):185-193.
219. Chen C., et al. Activation of antioxidant-response element (ARE), mitogen-activated protein kinases (MAPKs) and caspases by major green tea polyphenol components during cell survival and death. Arch. Pharm. Res. 2000, 23(6):605-612.
220. Brown G.C., Borutaite V. Inhibition of mitochondrial respiratory complex I by nitric oxide, peroxynitrite and S-nitrosothiols. Biochim. Biophys. Acta 2004, 1658(1-2):44-49.
221. Hill B.G., Darley-Usmar V.M. S-nitrosation and thiol switching in the mitochondrion: a new paradigm for cardioprotection in ischaemic preconditioning. Biochem. J. 2008, 412(2):e11-e13.
222. Taylor E.R., et al. Reversible glutathionylation of complex I increases mitochondrial superoxide formation. J. Biol. Chem. 2003, 278(22):19603-19610.
223. Chen C.L., et al. Site-specific S-glutathiolation of mitochondrial NADH ubiquinone reductase. Biochemistry 2007, 46(19):5754-5765.
224. Kang P.T., et al. Protein thiyl radical mediates S-glutathionylation of complex I. Free Radic. Biol. Med. 2012, 53(4):962-973.
225. Hurd T.R., et al. Complex I within oxidatively stressed bovine heart mitochondria is glutathionylated on Cys-531 and Cys-704 of the 75-kDa subunit: potential role of CYS residues in decreasing oxidative damage. J. Biol. Chem. 2008, 283(36):24801-24815.
226. Brookes P.S., et al. Mitochondria: regulators of signal transduction by reactive oxygen and nitrogen species. Free Radic. Biol. Med. 2002, 33(6):755-764.
227. Murray J., et al. Oxidative damage to mitochondrial complex I due to peroxynitrite: identification of reactive tyrosines by mass spectrometry. J. Biol. Chem. 2003, 278(39):37223-37230.
228. Abello N., et al. Protein tyrosine nitration: selectivity, physicochemical and biological consequences, denitration, and proteomics methods for the identification of tyrosine-nitrated proteins. J. Proteome Res. 2009, 8(7):3222-3238.
229. Chen C.L., et al. Protein tyrosine nitration of the flavin subunit is associated with oxidative modification of mitochondrial complex II in the post-ischemic myocardium. J. Biol. Chem. 2008, 283(41):27991-28003.
230. Yarian C.S., Rebrin I., Sohal R.S. Aconitase and ATP synthase are targets of malondialdehyde modification and undergo an age-related decrease in activity in mouse heart mitochondria. Biochem. Biophys. Res. Commun. 2005, 330(1):151-156.
231. Benderdour M., et al. Cardiac mitochondrial NADP+-isocitrate dehydrogenase is inactivated through 4-hydroxynonenal adduct formation: an event that precedes hypertrophy development. J Biol Chem 2003, 278(46):45154-45159.
232. Lee J.H., Yang E.S., Park J.W. Inactivation of NADP+-dependent isocitrate dehydrogenase by peroxynitrite. Implications for cytotoxicity and alcohol-induced liver injury. J. Biol. Chem. 2003, 278(51):51360-51371.
233. Lucas D.T., Szweda L.I. Declines in mitochondrial respiration during cardiac reperfusion: age-dependent inactivation of alpha-ketoglutarate dehydrogenase. Proc. Natl. Acad. Sci. USA 1999, 96(12):6689-6693.
234. McLain A.L., et al. Glutathionylation of alpha-ketoglutarate dehydrogenase: the chemical nature and relative susceptibility of the cofactor lipoic acid to modification. Free Radic. Biol. Med. 2013, 61:161-169.
235. Bulteau A.L., et al. Reversible redox-dependent modulation of mitochondrial aconitase and proteolytic activity during in vivo cardiac ischemia/reperfusion. Proc. Natl. Acad. Sci. USA 2005, 102(17):5987-5991.
236. Stachowiak O., et al. Mitochondrial creatine kinase is a prime target of peroxynitrite-induced modification and inactivation. J. Biol. Chem. 1998, 273(27):16694-16699.
237. Kim J., et al. Oxidative modification of cytochrome c by singlet oxygen. Free Radic. Biol. Med. 2008, 44(9):1700-1711.
238. Zarse K., et al. Impaired insulin/IGF1 signaling extends life span by promoting mitochondrial l-proline catabolism to induce a transient ROS signal. Cell Metab. 2012, 15(4):451-465.
239. Sena L.A., Chandel N.S. Physiological roles of mitochondrial reactive oxygen species. Mol. Cell 2012, 48(2):158-167.
240. Yun J., Finkel T. Mitohormesis. Cell Metab. 2014, 19(5):757-766.
241. Finkel T. Signal transduction by mitochondrial oxidants. J. Biol. Chem. 2012, 287(7):4434-4440.
242. Chandel N.S., et al. Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proc. Natl. Acad. Sci. USA 1998, 95(20):11715-11720.
243. Scherz-Shouval R., et al. Reactive oxygen species are essential for autophagy and specifically regulate the activity of Atg4. EMBO J. 2007, 26(7):1749-1760.
244. Adlam V.J., et al. Targeting an antioxidant to mitochondria decreases cardiac ischemia-reperfusion injury. FASEB J. 2005, 19(9):1088-1095.
245. Dare A.J., et al. Protection against renal ischemia-reperfusion injury in vivo by the mitochondria targeted antioxidant MitoQ. Redox Biol. 2015, 5:163-168.
246. Zhao W.Y., et al. Mitochondria-targeted antioxidant peptide SS31 prevents hypoxia/reoxygenation-induced apoptosis by down-regulating p66Shc in renal tubular epithelial cells. Cell. Physiol. Biochem. 2013, 32(3):591-600.
247. Dai W., et al. Bendavia, a mitochondria-targeting peptide, improves postinfarction cardiac function, prevents adverse left ventricular remodeling, and restores mitochondria-related gene expression in rats. J. Cardiovasc. Pharmacol. 2014, 64(6):543-553.
248. Tabara L.C., et al. Mitochondria-targeted therapies for acute kidney injury. Expert Rev. Mol. Med. 2014, 16:e13.
249. Ong S.B., et al. Inhibiting mitochondrial fission protects the heart against ischemia/reperfusion injury. Circulation 2010, 121(18):2012-2022.
250. Qi X., et al. A novel Drp1 inhibitor diminishes aberrant mitochondrial fission and neurotoxicity. J. Cell Sci. 2013, 126(3):789-802.
251. Kroemer G., Marino G., Levine B. Autophagy and the integrated stress response. Mol. Cell 2010, 40(2):280-293.
252. Andres A.M., et al. Mitophagy is required for acute cardioprotection by simvastatin. Antioxid. Redox Signal. 2014, 21(14):1960-1973.
253. 2 generation: redox signaling and oxidative stress. J. Biol. Chem. 2014, 289(13):8735-8741.